Home
Sign In
About
Curriculum
Activity Information
Target Audience
Learning Objectives
Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
Course materials have been developed for use outside of the United States.
|
 |
|
|
|
|
|
|
Genetic Forms of Iron Deficiency Anaemia
Clinical observations of unexplained forms of iron deficiency anaemia, coupled with growing evidence of inherited disorders and advances in knowledge concerning iron metabolism, have led to the description of five new genetic forms of iron deficiency anaemia. In this webcase, Dr. Photis Beris discusses these rare but important diseases and how to distinguish them from other forms of microcytic anaemia.
|
|
Faculty
|
|
|
Photis Beris, MD
Professor of Haematology
Chairman of the Department
of Haematology
National and Kapodistrian University
of Athens School of Medicine
Laiko University Hospital
Athens, Greece
|
|
|
Target Audience
This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of patients with genetic forms of iron deficiency anaemia.
|
Learning Objectives
After participating in this activity, participants should be better able to:
- Based on knowledge of their biologic and clinical features, differentiate between DMT1 mutation-related anaemia, glutaredoxin 5 mutation-related anaemia, hypotransferrinaemia/atransferrinaemia, aceruloplasminaemia, and iron refractory iron deficiency anaemia (IRIDA) in order to accurately identify and diagnose patients with these disorders.
- Based on the genetic mutations involved, apply your knowledge of the mechanisms of action of DMT1 mutation-related anaemia, glutaredoxin 5 mutation-related anaemia, hypotransferrinaemia/ atransferrinaemia, aceruloplasminaemia, and iron refractory iron deficiency anaemia (IRIDA) in order to better understand the pathology of these diseases.
|
Disclosure Information
Photis Beris, MD, Photis Beris, MD, has received grant/research support from, is on the speakers bureau of, and is on the advisory board for Novartis Pharmaceuticals Corporation; and is a consultant for Vifor International.
|
|
|
|
|
|
|
